azathioprine has been researched along with Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Achondroplasia is the commonest skeletal dysplasia of autosomal dominant inheritance caused by "gain of function" mutations in the fibroblast growth factor receptor 3 (FGFR3) gene." | 2.82 | Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update. ( Afshari, FT; Debenham, P; Parida, A; Solanki, GA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, FT | 1 |
| Parida, A | 1 |
| Debenham, P | 1 |
| Solanki, GA | 1 |
1 review available for azathioprine and Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans
| Article | Year |
|---|---|
Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update.
Topics: Achondroplasia; Anesthetics; Azathioprine; Child; Constriction, Pathologic; COVID-19; Female; Humans | 2022 |